Flash放疗设备
Search documents
四川省政协委员、绵阳市副市长胡进耀:加快提升核医疗和稀土永磁材料能级,培育壮大新兴产业
Mei Ri Jing Ji Xin Wen· 2026-02-04 10:54
Core Viewpoint - The Sichuan provincial government aims to accelerate the cultivation of emerging industries, particularly in nuclear medicine and rare earth permanent magnet materials, to enhance the province's economic development and establish Mianyang as a key industrial hub in these sectors [1][5]. Group 1: Emerging Industries - Mianyang is focusing on building a "587+" modern industrial system to promote breakthrough developments in emerging industries such as rare earth permanent magnet materials and nuclear medicine [1]. - The city is suggested to be included in the provincial "14th Five-Year Plan" for industrial development to support its ambition of becoming China's fourth city for magnetic materials [4][6]. - Mianyang has established a comprehensive industrial ecosystem for rare earth permanent magnet materials, with significant research capabilities and resource availability [2][4]. Group 2: Nuclear Medicine Industry - Sichuan province holds 80% of the national capacity for medical isotopes and has developed a full industrial chain from isotope preparation to clinical application [5]. - Mianyang is recognized as one of the four key areas in Sichuan for developing a world-class nuclear medicine industry, with several national and provincial innovation platforms established [6][7]. - The city is encouraged to optimize approval processes for innovative products in nuclear medicine to facilitate large-scale development [5][6]. Group 3: Collaboration and Development Strategies - Mianyang is advised to collaborate with neighboring cities like Leshan, Chengdu, and Luzhou to enhance the nuclear medicine industry through shared resources and expertise [7]. - The focus should be on reducing costs through local supply chains and accelerating the commercialization of core technologies in nuclear medicine [7]. - There is a need to address bottlenecks in the nuclear medicine industry by integrating mature products into insurance schemes and establishing industry standards [7].
创新成果闪耀世界 四川建设西部创新高地迈出坚实步伐
Zhong Guo Fa Zhan Wang· 2025-09-26 09:37
Core Insights - Sichuan Province is making significant strides in establishing itself as an innovation hub in Western China during the "14th Five-Year Plan" period, focusing on innovation-driven development strategies [2] Group 1: Comprehensive Innovation Capability - R&D expenditure in Sichuan is expected to reach approximately 150 billion yuan, a growth of over 40% compared to 2020, with basic research funding accounting for an estimated 6.5% of total R&D spending [3] - The province has seen a substantial increase in high-value invention patents, with a per capita ownership rate of 7.94 patents, which is 2.7 times that of 2020 [3] - The transaction volume of technology contracts has surpassed 260 billion yuan, doubling since 2020 [3] Group 2: Growth of High-tech Industries - The revenue from high-tech industries in Sichuan has increased from 31.9% to 40.9% of the total industrial output, marking a 9 percentage point rise [4] - Emerging industries such as artificial intelligence, biotechnology, and nuclear technology applications are projected to grow by over 20% in added value in 2024 [4] Group 3: High-level Innovation Platforms - The number of national-level innovation platforms in Sichuan has increased to 205, including the only national laboratory in Western China and 28 national key laboratories [5] - Major scientific facilities are being developed, including 10 national large scientific devices, with significant breakthroughs in various research areas [5] Group 4: Breakthroughs in Key Technologies - In aerospace, Sichuan has successfully completed major national projects and launched the world's first AI large model scientific satellite [6] - In the electronic information sector, significant advancements have been made in integrated circuits and software security, including the release of the first international gallium nitride quantum light source chip [6] - The biopharmaceutical sector has seen the approval of the first domestic TROP2 antibody-drug conjugate and the world's first trivalent COVID-19 vaccine for emergency use [6] Group 5: Innovation Entity Vitality - The number of high-tech enterprises in Sichuan has reached 19,000, a 2.4-fold increase since 2020, with a significant rise in technology-based SMEs [8] - Corporate R&D spending has increased by 58.4% compared to 2020, highlighting the strengthening of enterprises' roles in innovation [8] Group 6: Talent Development - Sichuan has implemented open talent policies, with the number of academicians reaching 67 and R&D personnel exceeding 400,000 [9] - The province has established a comprehensive talent service system, making it a key area for high-level talent innovation and entrepreneurship [9] Group 7: Regional Collaborative Innovation - Sichuan and Chongqing are jointly building the Western Science City and have established 11 joint key laboratories, enhancing collaborative innovation efforts [10] - Chengdu and Mianyang are positioned as major innovation engines, with Chengdu ranking 24th globally among tech clusters [10]